Multinational study of first-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer(LR/mBC): updated results of MO19391
- Kellokumpu-Lehtinen, P. (Contributor)
Activity: Talk or presentation › Conference presentation